Stroke Registration of Young Adults in China

NCT ID: NCT03024164

Last Updated: 2024-03-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-26

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multi-center, prospective,continuous registry study. The investigators will include 3000 young adult (18-45 years old) patients with confirmed first-ever acute ischemic stroke in China. The main purpose of this study is to build the study cohort of young ischemic stroke patients in China, and to compare the prognosis and stroke recurrence of young patients with different ischemic stroke subtypes. Secondary objectives are trying to find biomarkers of stroke recurrence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Approximately 10%-14% of all ischemic strokes occur in young adults ages 18 to 45 years old. Stroke etiology in this population differs by geographic region and has greater heterogeneity than in older individuals. Ascertain the definite etiologic classification in this young patients might be the key point to prevent the stroke recurrence and reduce the stroke burden. Advances in stroke diagnostic tests, particularly neuroimaging, refinement in classification schema. In this multi-center registry study conducted in China, we determine to explore the difference of prognosis and stroke recurrence of young patients with different ischemic stroke subtypes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Young adult stroke patients

Young adult (18-45 years old) patients with confirmed first-ever acute ischemic stroke

Treatment following current guidelines

Intervention Type OTHER

Treatment following current guidelines

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Treatment following current guidelines

Treatment following current guidelines

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 through 45 years, both genders
* First-ever acute ischemic stroke
* Onset of symptoms within 72 hours of inclusion
* Willing to participate in follow-up visits

Exclusion Criteria

* Silent stroke
* Failure to give their informed consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jiujiang No.1 People's Hospital

OTHER

Sponsor Role collaborator

Dezhou People's Hospital

OTHER

Sponsor Role collaborator

The Affiliated Hospital of Yanbian University

OTHER

Sponsor Role collaborator

First Affilated Hospital of Jiamusi University

UNKNOWN

Sponsor Role collaborator

Xuchang Central Hospital

UNKNOWN

Sponsor Role collaborator

Inner Mongolia People's Hospital

OTHER

Sponsor Role collaborator

Shaoxing People's Hospital

OTHER

Sponsor Role collaborator

Chinese PLA General Hospital

OTHER

Sponsor Role collaborator

General Hospital of Ningxia Medical University

OTHER

Sponsor Role collaborator

General Hospital of Shenyang Military Region

OTHER

Sponsor Role collaborator

Siping Central People's Hospital

OTHER

Sponsor Role collaborator

The First Affilated Hospital of the Medical College, Shihezi University

UNKNOWN

Sponsor Role collaborator

Daqing Oilfieled General Hospital

UNKNOWN

Sponsor Role collaborator

Heilongjiang Provicial Hospital

UNKNOWN

Sponsor Role collaborator

The First Affiliated Hospital of Soochow University

OTHER

Sponsor Role collaborator

Luoyang Central Hospital Affilated to Zhengzhou University

UNKNOWN

Sponsor Role collaborator

Wuzhou Red Cross Hospital

OTHER

Sponsor Role collaborator

Cangzhou Central Hospital

OTHER

Sponsor Role collaborator

Binzhou Medical University

OTHER

Sponsor Role collaborator

Affilated Hospital of Inner Mongolia University for the Nationalities

UNKNOWN

Sponsor Role collaborator

Fudan University Pudong Medical Center

UNKNOWN

Sponsor Role collaborator

Yi Yang

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yi Yang

Associate dean, Director of Cerebrovascular Disease Center

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

First Hospital of Jilin University

Changchun, Jilin, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yi Yang, MD,PhD

Role: CONTACT

+86-18186870008

Zhenni Guo, MD

Role: CONTACT

+86-18186872986

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yi Yang, MD, PhD

Role: primary

+86-18186870008

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REACH

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.